Portside Wealth Group’s Idexx Laboratories IDXX Stock Holding History

Portside Wealth Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Sell	2,963 -365	-11%	-$205K	0.18%	131
2026 Q1	$1.87M	Sell	3,328 -1,469	-31%	-$942K	0.25%	96
2025 Q4	$3.25M	Sell	4,797 -416	-8%	-$283K	0.44%	52
2025 Q3	$3.33M	Sell	5,213 -397	-7%	-$241K	0.46%	54
2025 Q2	$3.01M	Buy	5,610 +5,046	+895%	+$2.41M	0.45%	56
2025 Q1	$237K	Buy	+564	New	+$245K	0.04%	380

Other funds holding IDXX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Portside Wealth Group's IDXX Position: Q2 2026 in Review

Portside Wealth Group reduced its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, selling an estimated $205K and leaving 2,963 shares worth $1.56M. The position accounts for 0.18% of the portfolio, ranked #131.

Portside Wealth Group first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.33M in Q3 2025. 173 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Portside Wealth Group held 2,963 shares of Idexx Laboratories worth $1.56M as of Q2 2026.
Portside Wealth Group sold 365 Idexx Laboratories shares in Q2 2026, an estimated $205K.
Idexx Laboratories made up 0.18% of Portside Wealth Group's portfolio in Q2 2026, its #131 holding.
Portside Wealth Group first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
Portside Wealth Group's Idexx Laboratories position peaked at $3.33M in Q3 2025.
173 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.